Tesamorelin + Ipamorelin
In stockOne lyophilized vial supplying tesamorelin, a GHRH(1-44) analogue, and ipamorelin, a pentapeptide growth hormone secretagogue. Each component is also listed on its own page.
Supplied as a co-lyophilized vial with a colour-coded cap (Muscle Growth).
Research literature, not dosing or treatment instructions.
- Tesamorelin: Tesamorelin acts on the growth hormone-releasing hormone receptor, whose signal transduction and physiology are reviewed. (PMID 8993403)
- Ipamorelin: Growth hormone secretagogues act at a G-protein-coupled receptor of the pituitary and hypothalamus, cloned in 1996; ghrelin was later identified as its endogenous ligand. (PMID 8688086)
Add the solvent slowly along the vial wall; swirl gently, never shake. Allow to dissolve fully. Six-step guide with photos →
Concentration calculator only. Enter the mass being calculated; blend components are not added automatically. Products are for in-vitro research.
Refer to the product label and supplier documentation for storage conditions. Lot-specific storage and expiry information is not available here.
Each certificate is published with its lot number.
Questions about Tesamorelin + Ipamorelin
Is Tesamorelin + Ipamorelin an approved medicine?
Tesamorelin + Ipamorelin combines research compounds we also list on their own. It is not a medicinal product, and it is supplied for in-vitro laboratory research only, not for human or veterinary use. Regulator records are listed per component on the pages of Tesamorelin and Ipamorelin.
Which two compounds are in this vial?
Tesamorelin, human growth hormone-releasing factor (1-44) amide with a trans-3-hexenoyl group on Tyr1, and ipamorelin, a synthetic pentapeptide growth hormone secretagogue. They are listed separately as single compounds.
Is there published research on Tesamorelin + Ipamorelin as a combination?
No formulation-level literature is listed. Each component's page lists its own studies. The page of each component in the research library lists its own studies.
Is this product for human use?
No. Peptency products are supplied for in-vitro research only. Not for human or veterinary use, not for diagnosis or therapy.
Where can I find shipping information?
Current shipping rates and delivery information are on the Shipping & payment page, and the rates that apply to your order are shown at checkout.
Often studied with
For research use only. Not for human or veterinary use.
What is Tesamorelin + Ipamorelin?
A catalog item that supplies tesamorelin and ipamorelin together in one vial. Each component keeps its own chemistry, cited studies and regulator records, listed below. We supply Tesamorelin + Ipamorelin as a lyophilized vial for in-vitro laboratory research only.
What does a Tesamorelin + Ipamorelin vial contain?
Tesamorelin + Ipamorelin supplies Tesamorelin and Ipamorelin together in one vial. The single compounds are listed separately; the amount of each in the vial is shown on the product options.
- Tesamorelin: gHRH(1-44) analogue, hexenoylated (C221H366N72O67S, 5135.9 Da, CAS 218949-48-5).
- Ipamorelin: pentapeptide growth hormone secretagogue (C38H49N9O5, 711.9 Da, CAS 170851-70-4).
What does published research on Tesamorelin + Ipamorelin cover?
Tesamorelin + Ipamorelin combines compounds we also list on their own, so no study covers this exact vial. Each component has its own studies, checked in PubMed on 5 October 2026. One cited study per component follows.
- Tesamorelin: Tesamorelin acts on the growth hormone-releasing hormone receptor, whose signal transduction and physiology are reviewed. (Mayo et al., Ann N Y Acad Sci, 1996; PMID 8993403)
- Ipamorelin: Growth hormone secretagogues act at a G-protein-coupled receptor of the pituitary and hypothalamus, cloned in 1996; ghrelin was later identified as its endogenous ligand. (Howard et al., Science, 1996; PMID 8688086)
Mechanism, every cited study and the regulator records are on the Tesamorelin + Ipamorelin page of the research library. Papers are listed by what they measured, not as evidence of any use.
How is Tesamorelin + Ipamorelin supplied and stored?
Tesamorelin + Ipamorelin is supplied as a co-lyophilized (freeze-dried) powder in a sealed vial, for in-vitro laboratory research only. Our stated storage condition for the sealed lyophilized vial is 2 to 8 °C. The label and the lot certificate carry the lot-specific storage condition and expiry date.
What is the regulatory status of Tesamorelin + Ipamorelin?
Tesamorelin + Ipamorelin combines research compounds we also list on their own. It is not a medicinal product. Regulator records are listed per component.
Tesamorelin: Drugs@FDA lists 1 application naming this active ingredient, marketing status as listed: Prescription (checked 5 October 2026). Those are medicinal products. The research material we supply is not one of them.
Ipamorelin: Drugs@FDA lists no application naming ipamorelin as an active ingredient (checked 5 October 2026).
A regulator record is information about a database entry. It is not advice and not a statement that any use is lawful or unlawful in any country. How regulators approach research peptides.
Which related research pages and compounds are listed?
- Tesamorelin + Ipamorelin: chemistry, literature and regulatory status
- How to read a certificate of analysis
Components in the catalog: